Dr. Jordan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8700 Beverly BLD
Los Angeles, CA 90048Phone+1 310-423-2641Fax+1 310-967-1800
Summary
- Dr. Stanley Jordan is a nephrologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Cedars-Sinai Medical Center and Ronald Reagan UCLA Medical Center. He received his medical degree from University of North Carolina at Chapel Hill School of Medicine and has been in practice 44 years. He specializes in glomerular disease and kidney & pancreas transplantation and is experienced in transplant nephrology, glomerular disease, anti-glomerular basement membrane disease, focal segmental glomerulosclerosis, and membranous glomerulonephritis.
Education & Training
- Children's Hospital Los AngelesFellowship, Pediatric Nephrology, 1978 - 1979
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Nephrology, 1976 - 1977
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1973 - 1976
- University of North Carolina at Chapel Hill School of MedicineClass of 1973
Certifications & Licensure
- CA State Medical License 1974 - 2025
- NC State Medical License 1973 - 1998
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Diagnostic Laboratory Immunology
- American Board of Pediatrics Pediatric Nephrology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation Start of enrollment: 2005 Sep 01
- Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection Start of enrollment: 2011 Aug 01
- Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation Start of enrollment: 2013 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 25 citationsSoluble CTLA4Ig modifies parameters of acute inflammation in rat lung allograft rejection without altering lymphocytic infiltration or transcription of key cytokines.Yuji Matsumura, Xio-Jing Zuo, John Prehn, Peter S. Linsley, Alberto M. Marchevsky
Transplantation. 1995-02-27 - 29 citationsEvaluation of Clazakizumab (Anti-Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts.Stanley C Jordan, Noriko Ammerman, Jua Choi, Edmund Huang, Reiad Najjar
Kidney International Reports. 2022-04-01 - 353 citations1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells.J. M. Lemire, John S. Adams, R. Sakai, S C Jordan
The Journal of Clinical Investigation. 1984-08-01
Press Mentions
- Clinical Trial Highlights Efficacy of Imlifidase for Kidney Transplant RecipientsOctober 26th, 2024
- Cedars-Sinai Performs a Record-Setting Number of Solid Organ Transplants in 2022April 25th, 2023
- Tipsheet: Cedars-Sinai Clinicians and Investigators Present Research at American Transplant CongressJune 3rd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: